drugset / Trial / NCT01397084

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

NCT01397084

Phase 4 Completed 107 enrolled AstraZeneca Parexel · collab
NaSingle-groupOpen-labelTreatment

Summary

Administration of esomeprazole 20 mg to subjects who still had heartburn after receiving rabeprazole 10 mg once daily for at least 4 weeks will result in statistically significant improvement of heartburn after 8-week treatment.

Timeline

Start
2011-08
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg